Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Cancer Research|July 15, 1990
Improved in vivo stability and tumor targeting of bismuth-labeled antibodyC L Ruegg, W T Anderson-Berg, M W Brechbiel, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 24, 2009
Production of Sn-117m in the BR2 high-flux reactorB Ponsard, S C Srivastava, L F Mausner, et al.Journal of Medicinal Chemistry|August 28, 1998
Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugatesT J McMurry, C G Pippin, C Wu, et al.Cancer Research|December 1, 1993
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapyR P Junghans, D Dobbs, M W Brechbiel, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 25, 2003
Neutron flux characterization of a peripheral target position in the High Flux Isotope ReactorM A Garland, S Mirzadeh, C W Alexander, et al.Cancer Biotherapy & Radiopharmaceuticals|June 2, 2001
In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelatesD E Milenic, M Roselli, S Mirzadeh, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenograftsM Roselli, D E Milenic, M W Brechbiel, et al.International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodiesM Roselli, J Schlom, O A Gansow, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Therapy of rat tracheal carcinoma IC-12 in SCID mice: vascular targeting with [213Bi]-MAb TES-23S J Kennel, T Lankford, S Davern, et al.Cancer Biotherapy & Radiopharmaceuticals|August 15, 2000
Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumorsS J Kennel, L L Chappell, K Dadachova, et al.Pageof 5